SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John S. Sturges who wrote (223)12/24/1997 5:43:00 AM
From: Jongmans  Read Replies (1) of 4474
 
I fully agree with your view on Ariad.

Among Ariad's research-objectives in particular its systematic building of a very srong patent-position around its system of pharmocologic regulation of gene- and celltherapy is in my view interesting.This, in the long run probably very rewarding, technology
seems complimentary to most current efforts in this field.

Aside of that, Ariad has expanded its research-capabilities in a big way by its joint-venture with Hoechst Marion Roussel. Hoechst-Ariad Genomics CenterLLC will have full access to all relevant technologies of both partners AND both partners have equal rights to the candidate therapeutic proteins and drugtargets, developed within this joint-venture.

And last, not least:

Ariad's part of the $ 85million investment in this joint-venture is financed by HMR's purchase for of 2.4 million shares for $ 25million and by additional purchases of a maximum of 1.8 million shares for $ 25 million (an average price of at least $ 11.40) It gives an indication of how highly Ariad's research-capabilities and input are valued within the pharmaceutical industry.

This joint venture will now, probably, be fully staffed, equiped and
operational.

I'm still happy with my position in Ariad!

Best regards,

Martin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News